SEI Investments’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.36M | Buy |
98,162
+28,350
| +41% | +$2.04M | 0.01% | 1222 |
|
|
2026
Q1 | $4.6M | Sell |
69,812
-427
| -0.6% | -$27.1K | ﹤0.01% | 1587 |
|
|
2025
Q4 | $4.46M | Buy |
70,239
+1,467
| +2% | +$91.3K | ﹤0.01% | 1427 |
|
|
2025
Q3 | $3.78M | Buy |
68,772
+12,367
| +22% | +$509K | ﹤0.01% | 1424 |
|
|
2025
Q2 | $1.86M | Sell |
56,405
-34,945
| -38% | -$1.22M | ﹤0.01% | 1677 |
|
|
2025
Q1 | $3.67M | Buy |
91,350
+1,790
| +2% | +$82.3K | ﹤0.01% | 1396 |
|
|
2024
Q4 | $4.21M | Sell |
89,560
-1,472
| -2% | -$76.4K | 0.01% | 1375 |
|
|
2024
Q3 | $4.81M | Buy |
91,032
+28,023
| +44% | +$1.56M | 0.01% | 1300 |
|
|
2024
Q2 | $3.41M | Buy |
63,009
+4,695
| +8% | +$283K | ﹤0.01% | 1396 |
|
|
2024
Q1 | $4.09M | Buy |
58,314
+9,779
| +20% | +$756K | 0.01% | 1299 |
|
|
2023
Q4 | $4.05M | Sell |
48,535
-9,088
| -16% | -$329K | 0.01% | 1272 |
|
|
2023
Q3 | $1.7M | Buy |
57,623
+3,358
| +6% | +$112K | ﹤0.01% | 1665 |
|
|
2023
Q2 | $1.77M | Sell |
54,265
-39,118
| -42% | -$1.45M | ﹤0.01% | 1680 |
|
|
2023
Q1 | $3.29M | Buy |
93,383
+62,758
| +205% | +$2.56M | 0.01% | 1396 |
|
|
2022
Q4 | $1.4M | Sell |
30,625
-83,256
| -73% | -$3.58M | ﹤0.01% | 1644 |
|
|
2022
Q3 | $5.52M | Buy |
113,881
+10,112
| +10% | +$487K | 0.01% | 1045 |
|
|
2022
Q2 | $4.08M | Buy |
103,769
+34,329
| +49% | +$1.38M | 0.01% | 1201 |
|
|
2022
Q1 | $2.56M | Sell |
69,440
-4,895
| -7% | -$174K | 0.01% | 1444 |
|
|
2021
Q4 | $3.39M | Sell |
74,335
-2,136
| -3% | -$82.4K | 0.01% | 1339 |
|
|
2021
Q3 | $2.73M | Buy |
76,471
+46,054
| +151% | +$1.36M | 0.01% | 1374 |
|
|
2021
Q2 | $593K | Buy |
30,417
+574
| +2% | +$13.5K | ﹤0.01% | 2007 |
|
|
2021
Q1 | $694K | Sell |
29,843
-3,432
| -10% | -$73.3K | ﹤0.01% | 1892 |
|
|
2020
Q4 | $691K | Buy |
+33,275
| New | +$608K | ﹤0.01% | 1842 |
|
|
2020
Q3 | – | Sell |
-21,326
| Closed | -$503K | – | 2422 |
|
|
2020
Q2 | $503K | Buy |
+21,326
| New | +$400K | ﹤0.01% | 1844 |
|
|
2018
Q1 | – | Sell |
-14
| Closed | – | – | 3500 |
|
|
2017
Q4 | $0 | Buy |
+14
| New | +$159 | ﹤0.01% | 3358 |
|
|
2017
Q2 | – | Sell |
-23
| Closed | – | – | 3109 |
|
|
2017
Q1 | $0 | Buy |
+23
| New | +$269 | ﹤0.01% | 2936 |
|
|
2016
Q1 | – | Sell |
-109
| Closed | -$1K | – | 2522 |
|
|
2015
Q4 | $1K | Buy |
109
+29
| +36% | +$284 | ﹤0.01% | 2427 |
|
|
2015
Q3 | $1K | Buy |
+80
| New | +$546 | ﹤0.01% | 2407 |
|
Other funds holding CYTK
ACA
SEI Investments's CYTK Position: Q2 2026 in Review
SEI Investments increased its Cytokinetics (CYTK) stake by 41% in Q2 2026, buying an estimated $2.04M and bringing the position to 98,162 shares worth $8.36M. The position accounts for 0.01% of the portfolio, ranked #1222.
SEI Investments first reported a position in CYTK in Q3 2015 and has held it in 28 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.
- SEI Investments held 98,162 shares of Cytokinetics worth $8.36M as of Q2 2026.
- SEI Investments bought 28,350 Cytokinetics shares in Q2 2026, an estimated $2.04M.
- Cytokinetics made up 0.01% of SEI Investments's portfolio in Q2 2026, its #1222 holding.
- SEI Investments first reported a position in Cytokinetics in Q3 2015 and has held it in 28 quarters since.
- 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.
Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.